High risk of renal dysfunction in patients with fulminant type 1 diabetes

Nobuyuki Takahashi1,2, Tetsuro Tsujimoto1, Daisuke Chujo1

  • 1Department of Diabetes, Endocrinology, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.

Insights

Patients with fulminant type 1 diabetes face a higher risk of renal dysfunction compared to those with acute-onset type 1 diabetes. This increased risk persists even with better glycemic control in fulminant type 1 diabetes cases.

Area of Science:

  • Endocrinology
  • Nephrology
  • Diabetology

Background:

  • Type 1 diabetes presents with varying clinical courses, including fulminant and acute-onset forms.
  • Renal dysfunction is a significant complication of diabetes, impacting patient outcomes.
  • Understanding the differential risk of renal complications between diabetes subtypes is crucial for targeted management.

Purpose of the Study:

  • To compare the incidence rate of renal dysfunction between patients diagnosed with fulminant type 1 diabetes and those with acute-onset type 1 diabetes.
  • To investigate the association between diabetes type and the development of renal impairment.

Main Methods:

  • A retrospective cohort study was conducted involving patients diagnosed with fulminant or acute-onset type 1 diabetes between 1993 and 2016.
  • Key metrics analyzed included glycated hemoglobin levels, incidence of renal dysfunction (eGFR <60 mL/min/1.73 m²), and microalbuminuria.
  • Kaplan-Meier analysis and sensitivity analyses were employed to compare outcomes between the two groups.

Main Results:

  • The study included 115 patients: 10 with fulminant type 1 diabetes and 105 with acute-onset type 1 diabetes.
  • Patients with fulminant type 1 diabetes exhibited significantly lower glycated hemoglobin levels throughout the follow-up period compared to the acute-onset group.
  • A significantly higher incidence rate of renal dysfunction was observed in the fulminant type 1 diabetes group (HR 1.72, P=0.037), while microalbuminuria rates did not differ significantly.

Conclusions:

  • Fulminant type 1 diabetes is associated with an elevated risk of developing renal dysfunction compared to acute-onset type 1 diabetes.
  • This increased renal risk in fulminant type 1 diabetes occurs despite achieving better glycemic control.
  • The findings highlight the importance of monitoring renal function closely in patients with fulminant type 1 diabetes.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.0K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
547
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
434
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
419